CBAVE Stock Overview

A medical company, operates a network of ophthalmology clinics. More details

CBAVE fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	5/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 59.4% below our estimate of its fair value

Earnings grew by 22.5% over the past year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

My Notes

Capture your thoughts, links and company narrative

Clínica Baviera, S.A. Competitors

CVS Group

AIM:CVSG

UK£602.6m

Spire Healthcare Group

LSE:SPI

UK£910.6m

Mediclinic International

LSE:MDC

UK£3.7b

Advanced Medical Solutions Group

AIM:AMS

UK£430.5m

Price History & Performance

Summary of share price highs, lows and changes for Clínica Baviera
Historical stock prices
Current Share Price	€27.70
52 Week High	€27.70
52 Week Low	€27.70
Beta	0.67
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	151.82%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CBAVE	GB Healthcare	GB Market
7D	0%	0.3%	0.4%
1Y	n/a	-23.7%	3.3%

Return vs Industry: Insufficient data to determine how CBAVE performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how CBAVE performed against the UK Market.

Price Volatility

Is CBAVE's price volatile compared to industry and market?
CBAVE volatility
CBAVE Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.4%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: CBAVE has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CBAVE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	1,326	Eduardo Baviera Sabater	www.clinicabaviera.com

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.

Clínica Baviera, S.A. Fundamentals Summary

How do Clínica Baviera's earnings and revenue compare to its market cap?
CBAVE fundamental statistics
Market cap	€493.96m
Earnings (TTM)	€38.41m
Revenue (TTM)	€243.31m

12.9x

P/E Ratio

2.0x

P/S Ratio

Is CBAVE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBAVE income statement (TTM)
Revenue	€243.31m
Cost of Revenue	€122.92m
Gross Profit	€120.39m
Other Expenses	€81.98m
Earnings	€38.41m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.36
Gross Margin	49.48%
Net Profit Margin	15.79%
Debt/Equity Ratio	1.9%

How did CBAVE perform over the long term?

See historical performance and comparison

Dividends

5.2%

Current Dividend Yield

67%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/09/01 10:28
End of Day Share Price	2024/06/05 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clínica Baviera, S.A. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ignacio Ortiz de Mendivil	Banco BPI, S.A.
León Izuzquiza Lenze	Banco de Sabadell. S.A.
Marta Diaz	Banco de Sabadell. S.A.